Key Financial Data Of Group

Chiome Bioscience Inc. - Filing #7593791

Concept As at
2022-06-30
2022-04-01 to
2022-06-30
2022-01-01 to
2022-06-30
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-06-30
As at
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of group
Business results of group
Net sales
278,211,000 JPY
712,932,000 JPY
384,932,000 JPY
Ordinary profit (loss)
-768,686,000 JPY
-1,329,312,000 JPY
-409,402,000 JPY
Net assets
1,476,135,000 JPY
1,893,049,000 JPY
2,858,871,000 JPY
Total assets
1,920,212,000 JPY
2,339,439,000 JPY
3,328,800,000 JPY
Basic earnings (loss) per share
-6.53
-18.17
-36.74
-10.16
-6.16
Diluted earnings per share
Equity-to-asset ratio
0.753 xbrli:pure
0.794 xbrli:pure
0.853 xbrli:pure
Net cash provided by (used in) operating activities
-660,225,000 JPY
-1,131,291,000 JPY
-560,856,000 JPY
Net cash provided by (used in) investing activities
JPY
-35,384,000 JPY
JPY
Net cash provided by (used in) financing activities
341,172,000 JPY
271,345,000 JPY
176,141,000 JPY
Cash and cash equivalents
1,471,935,000 JPY
1,790,988,000 JPY
2,301,603,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.